Skip to main content
. 2021 May 26;28(2):145–151. doi: 10.1177/15910199211019175

Table 1.

Patient demographics and presentation, n=29.

Age 38 years (IQR 27)
Sex (F:M) 1.2:1
N (Percent)
Presenting symptoms
– Hearing loss 11 (37.9%)
– Lower cranial nerve symptoms 7 (24.1%)
– Facial weakness 4 (13.7%)
– Pulsatile tinnitus 4 (13.7%)
– Bruit 2 (6.9%)
– Papilledema 1 (3.5%)
– Palpable/fungating mass 2 (6.9%)
– Incidental 1 (3.5%)
Facial nerve function
– Good facial nerve function (HB 1–2) 25 (86.3%)
– Poor facial nerve function (HB 3–6) 4 (13.7%)
Signs of vagal nerve paresis 11 (37.9%)
Functioning tumors 3 (10.3%)
Tumor size (greatest axial diameter) 3.4 ± 1.8 cm